Navigation Links
QMed, Inc. Extends Agreement & Receives $550,000 Performance Bonus
Date:10/8/2007

EATONTOWN, N.J., Oct. 8 /PRNewswire-FirstCall/ -- QMed, Inc., (Nasdaq: QMED) today announced that it has extended its agreement with a health plan customer for an additional three years. Under the terms of the agreement, QMed will continue to provide its interventions for stroke and coronary heart disease. In addition, the Company receives a bonus of $550,000 for having achieved specific quality and financial performance measures.

Jane Murray, QMed president and CEO said, "We are obviously gratified to continue our relationship with this health plan. Just as importantly, and consistent with our historical experience, our interventions have shown positive health and financial outcomes in both commercial and Medicare populations," she concluded.

About QMed, Inc.

QMed provides evidence-based clinical information management systems around the country to its health plan customers. The system incorporates Disease Management services to patients and decision support to physicians. The Company's QMedCare subsidiary specializes in serving high-risk populations of Medicare beneficiaries. The Company also operates a Medicare Demonstration to test the feasibility of reimbursing its care coordinated DM services in the vast Medicare fee-for-service program. More information on QMed, Inc. can be obtained at http://www.qmedinc.com, by calling (732) 544-5544 or by emailing investor@qmedinc.com.

Except for historical information contained herein, matters discussed in this news release are forward-looking statements that involve risks and uncertainties. They include but are not limited to those relating to the timely implementation of programs, the impact of competitive product introductions, acceptance and pricing, and those risks detailed in the Company's filings with the Securities and Exchange Commission (SEC). Actual results may differ materially from any forward-looking statements due to these risks and uncertainties.


'/>"/>
SOURCE QMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. India extends National TB Control Program
2. Irish Medicines Board Extends Paracetamol Recall To All Batches
3. Treatment Extends Survival in Mouse Model of Spinal Muscular Atrophy
4. Caloric Restriction in Non-obese People Extends Life Span
5. Vitamin Extends Life in Yeast, Dartmouth Medical School Researchers Find
6. Nexavar Significantly Extends Survival of Liver Cancer Patients
7. Ranbaxy Labs Extends Roots in South Africa
8. Vitamin Extends Life in Yeast, Dartmouth Medical School Researchers Find
9. Singapore Extends Smoking Ban to Pubs, Nightclubs
10. CCEA Extends National TB Control Project for Five Years
11. FDA Extends GRAS Approval Listex to All Food Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... ... CloudLIMS, joins an elite number of companies that have earned a spot on ... CIOReview. , In a deliberate session with the honorary industrial experts, a list of ... with. The positioning is based on evaluation of CloudLIMS’ specialties in Automated Sample Management ...
(Date:5/25/2016)... ... 25, 2016 , ... DKT International, one of the largest ... pleased to release their 2015 global impact data. In 2015, DKT served over ... deaths and 3.8 million unsafe abortions across 21 countries worldwide. , “We ...
(Date:5/25/2016)... Mexico (PRWEB) , ... May 25, 2016 , ... Casa ... the restorative properties of precious stones to complement its new wellness suites . ... two floors and feature a plethora of special services and insuite amenities, from a ...
(Date:5/25/2016)... ... ... more than fifty years, we've suffered whiplash as each new scientific study seemed to contradict ... nutritional advice – advice that was supposed to keep us healthy and slim. And what ... are considered to be overweight and more than 1 in 3 adults are considered to ...
(Date:5/25/2016)... ... 25, 2016 , ... Researchers from SUNY State College of Optometry won the ... visual evoked potential and human attention. The article, VEP and Human Attention: Translation ... ERG and VEP Vision Testing System (Diopsys, Inc., Pine Brook, NJ) to record ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)...   , Study met both ... in , Excellent plus Good ... of the ascending colon   ,      ... announced new positive data from the phase III MORA study for ... litre PEG with ascorbate. The study met both primary endpoints showing ...
(Date:5/24/2016)... 2016 ARANZ Medical  Ltd a ... sector, has been named the Coretex Hi-Tech Emerging Company of ... Dr Bruce Davey , CEO of ARANZ Medical ... really good to be recognised for the work we are ... used in 35 countries around the world from Sub-Saharan Africa ...
(Date:5/24/2016)... 2016 Celsion Corporation (NASDAQ: ... provided an update on its ongoing OVATION study, ... GEN-1, the Company,s DNA-based immunotherapy, with the standard ... with advanced ovarian cancer who will undergo neoadjuvant ... an IL-12 DNA plasmid vector formulated as a ...
Breaking Medicine Technology: